The Value of Vision – the case for investing in eye health
Investing $7 billion USD in eye health in LMICs over 2026-2030 will deliver $199 billion USD in economic benefits, a 1:28 return on investment – one of the best in global health. Plus:
The Value of Vision
Our new Investment Case, launched at the 79th United Nations General Assembly, outlines the economic costs and benefits of addressing sight loss and provides a clear and actionable path for countries to deliver an immediate positive impact on economies, workforces, schools and communities.
The Global Summit is supported by a wider messaging campaign around the tangible and undeniable ‘Value of Vision’. The phrase is our central organising thought for 2026, and the evidence, including our new research on the return of investment and impact on work, education and communities, will be the core part of all our communications.
The ‘Value of Vision’ provides the basis for a clear narrative and messaging which will resonate, helping to ensure the summit is successful, impactful and its outcomes are enduring. But it will also provide the broader context in which we will continue to educate and change behaviours and attitudes with the public and influence change outside of the event.
Making the world see the Value of Vision
The burden of eye health already costs the global economy billions every year. But for the first time, research in ‘The Value of Vision – the Case for Investing In Eye Health’ shows the huge economic return that is possible with targeted investment. Every $1 invested in eye health can yield a $28 return in low- and middle- income countries.
